Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, March 28, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Joseph Stringer Reiterated (CARA) at Strong Buy and Held Target at $5 on, Mar 28th, 2024
Joseph Stringer of Needham, Reiterated "Cara Therapeutics, Inc." (CARA) at Strong Buy and Held Target at $5 on, Mar 28th, 2024.
Joseph has made no other calls on CARA in the last 4 months.
There are 2 other peers that have a rating on CARA. Out of the 2 peers that are also analyzing CARA, 0 agree with Joseph's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Joseph
- Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $10 on, Wednesday, March 6th, 2024
- Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $2.5 on, Tuesday, December 19th, 2023
